Navigation Links
Prospect Therapeutics, Inc. Assigns All Its Assets to Joseph F. Finn, Jr., C.P.A. for the Benefit of Its Creditors
Date:5/12/2009

WELLESLEY HILLS, Mass., May 12 /PRNewswire/ -- Joseph F. Finn, Jr., C.P.A. ("Finn"), announced today that assets of Prospect Therapeutics, Inc. ("Prospect") have been assigned to him for the benefit of Prospect's creditors.

Prospect's lead product candidate, GCS-100, is a carbohydrate molecule designed to inhibit the activity of galectin-3, a protein found in high concentration in a broad range of human cancers and whose over-expression is associated with poor prognosis in cancer patients. It is presently in Phase 2 clinical trials. The intellectual property, regulatory dossier, fixed assets and clinical inventory will be sold at auction on Monday, June 29, 2009 at 12:00 noon.

Persons interested in bidding must sign a Confidentiality Agreement ("CA") obtained from Finn's Office - jffinnjr@earthlink.net or 781-237-8840. They will then receive a bid package.

About Joseph F. Finn, Jr., C.P.A.

Joseph F. Finn, Jr., C.P.A. is the founding partner of the firm, Finn, Warnke & Gayton, Certified Public Accountants of Wellesley Hills, Massachusetts. He works primarily in the area of management consulting for distressed enterprises, bankruptcy accounting and related matters, such as assignee for the benefit of creditors and liquidating agent for a corporation. He has been involved in a number of loan workouts and bankruptcy cases for thirty-five (35) years. His most recent Assignment for the Benefit of Creditors in the biotech field was Spherics, Inc. and ActivBiotics, Inc.

For further information, please contact Joseph F. Finn, Jr., C.P.A. at 781-237-8840 or jffinnjr@earthlink.net'/>"/>

SOURCE Joseph F. Finn, Jr., C.P.A.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Publication of Supplementary Prospectus
2. Pro Football Prospects Training at TEST Sports Clubs(TM) Use SURGEX(TM) as Part of Their Pre-Combine Training Regime
3. Cell Therapeutics, Inc. Announces Authorization to Publish Italian Listing Prospectus
4. Cell Therapeutics, Inc. (CTI) to Report 2009 First Quarter Financial Results on May 7
5. Oxygen Biotherapeutics, Inc. Signs Supply Agreement for Clinical-Grade Oxycyte for Clinical Trials and Future Needs
6. Cell Therapeutics, Inc. Announces Single Institutional Investor Purchases $15 Million of Preferred Stock
7. Oxygen Biotherapeutics, Inc. CEO Posts New Blog Entry
8. Stockholder Suits Related to TorreyPines Therapeutics, Inc. Dismissed
9. Webcast Alert: Oxygen Biotherapeutics, Inc. Investor Meeting in Zurich, Switzerland
10. Oxygen Biotherapeutics, Inc. Adds Oxycyte TBI Clinical Trial Sites in Israel
11. Cell Therapeutics, Inc. Reports Outcome of Special Meeting of Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Rochester, NY (PRWEB) January 15, 2014 The ... cause a major disease. One of these latent viruses is ... is rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... the theory, a study found that RA patients have high ...
(Date:1/15/2014)... AudioNotch is the internet's leading provider of Notched ... tinnitus. Patients listen to sound therapy that is tailor-made ... weeks to months, their tinnitus volume decreases. , AudioNotch has ... and Notched White Noise. Now, AudioNotch is pleased to announce ...
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine company ... under simulated embryonic conditions, today announced that they have ... Inc. for physician-dispensed aesthetic products containing Histogen’s proprietary multipotent ... is an amendment to the existing license between Histogen ...
(Date:1/14/2014)... 2014 The largest international professional organization of ... therapeutic derivatives thereof has endorsed an educational program ... the challenges of adulterated herb and botanical products. ... The Society for Medicinal Plant and Natural ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8
... June 3 OriGene Technologies, Inc., a leading gene-centric ... of over 5,000 heavy isotope labeled human proteins as internal standards ... The announcement was made at the 2010 American Society for ... , , ...
... 3 Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today that ... executive vice president and CFO, will provide an update on the progress of ... at two investor conferences during the month of June: , ... The Jefferies 2010 Global Life ...
... YORK , June 3 Reportlinker.com announces that a new market research report is ... Nanobiotechnologies- applications, markets and companies ... http://www.reportlinker.com/p0203545/Nanobiotechnologies--applications-markets-and-companies.html , , ... , , ...
Cached Biology Technology:OriGene Technologies Launches Over 5,000 Heavy Isotope Labeled Full-Length Human Proteins as Quantitative Internal Standards for SRM/MRM Mass Spectrometry 2Sangamo BioSciences Announces Presentation at Two Upcoming Investor Conferences 2Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 2Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 3Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 4Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 5Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 6Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 7Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 8Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 9Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 10Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 11Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 12Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 13Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 14Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 15Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 16Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 17Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 18Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 19Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 20Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 21Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 22Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 23Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 24Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 25Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 26Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 27Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 28Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 29Reportlinker Adds Nanobiotechnologies- Applications, Markets and Companies 30
(Date:4/18/2014)... URBANA, Ill. For the past 20 years, researchers ... of the research findings have suggested that soil organic ... or conventional tillage systems to no-till systems. However, there ... no-till systems in corn and soybean rotations without cover ... soil organic carbon stocks at the published rates. , ...
(Date:4/17/2014)... In the most densely forested and most densely ... centuries of human needs, values and practices. Disturbances associated ... for agriculture and development, have set the stage for ... Service study reports. , The report Five anthropogenic ... needs in the Northern United States was ...
(Date:4/17/2014)... 2014. Kessler Foundation has been named awardee of ... Department of Defense Spinal Cord Injury Research Program. ... the randomized, double-blinded, controlled, multi-site clinical trial, which ... strength after spinal cord injury. Dr. Forrest is ... at Kessler Foundation. Two additional sites will participate ...
Breaking Biology News(10 mins):Researchers question published no-till soil organic carbon sequestration rates 2Researchers question published no-till soil organic carbon sequestration rates 3Researchers question published no-till soil organic carbon sequestration rates 4Five anthropogenic factors that will radically alter northern forests in 50 years 2Five anthropogenic factors that will radically alter northern forests in 50 years 3Kessler Foundation awarded Department of Defense grant for spinal cord injury research 2
... WASHINGTON Pets can serve as important sources of ... facing significant health challenges, according to research published by the ... owners were just as close to key people in their ... with pets came at the expense of relationships with other ...
... of the poisonous shrub Jatropha curcas acts as ... different from conventional analgesics, such as morphine and other pharmaceuticals. ... the International Journal of Biomedical Engineering and Technology . ... University of Agriculture in Umudike, Nigeria, explain how J. ...
... This release is available in French . ... in patients but not in their parents are more ... an international group of scientists led by Dr. Guy A. ... The discovery, published today in Nature Genetics , may ...
Cached Biology News:The truth about cats and dogs: Pets are good for mental health of 'everyday people' 2Natural pain relief from poisonous shrub 2New genetic clues for schizophrenia 2
... 30 L samples, featuring 24-position turntable. Provides up to 30 minutes of walkaway time. ... analysis and record keeping. RS-232 port. ... ... ...
Vybrant® Multidrug Resistance Assay Kit...
...
... The CultureWell cell culture systems provide ... cells for staining and imaging. Each ... with standard optical-quality coverslips in cell ... provided sterile and ready to use. ...
Biology Products: